Patents by Inventor MediciNova, Inc.

MediciNova, Inc. has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF ACUTE EXACERBATION OF ASTHMA AND REDUCTION OF LIKELIHOOD OF HOSPITALIZATION OF PATIENTS SUFFERING THEREFROM
    Publication number: 20140056999
    Abstract: The invention provides a method of improving one or more clinical outcomes of an individual experiencing an acute respiratory attack. The acute respiratory attack may include acute reversible bronchospasm, severe acute bronchospasm, or acute exacerbation of asthma. The method includes administering to an individual suffering from an acute respiratory attack an effective amount of bedoradrine or a pharmaceutically acceptable salt thereof in combination with a standard of care (SOC) treatment regimen.
    Type: Application
    Filed: March 7, 2013
    Publication date: February 27, 2014
    Applicant: MediciNova, Inc.
    Inventor: MediciNova, Inc.
  • TREATMENT OF PROGRESSIVE NEURODEGERATIVE DISEASE WITH IBUDILAST
    Publication number: 20130217718
    Abstract: Compositions and methods for treating progressive neurodegenerative diseases, and their associated symptoms by administration of ibudilast (3-isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine).
    Type: Application
    Filed: December 21, 2012
    Publication date: August 22, 2013
    Applicant: MediciNova, Inc.
    Inventor: MediciNova, Inc.
  • IBUDILAST FOR RELIEVING NEGATIVE EFFECTS OF MEDICATION OVERUSE HEADACHE
    Publication number: 20130178495
    Abstract: Certain negative effects of medication overuse headache (MOH) are relieved by administering ibudilast or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: December 12, 2012
    Publication date: July 11, 2013
    Applicants: MediciNova, Inc., Adelaide Research & Innovation Pty Ltd.
    Inventors: Adelaide Research & Innovation Pty Ltd., MediciNova, Inc.
  • METHOD OF TREATING NON-ALCOHOLIC FATTY LIVER DISEASE AND STEATOHEPATITIS
    Publication number: 20130158123
    Abstract: A compound of Formula (I): or a metabolite thereof, or an ester of the compound of Formula (I) or the metabolite thereof, or a pharmaceutically acceptable salt of each thereof, wherein m, n, X1 and X2 are as defined herein, is useful for treating non-alcoholic fatty liver disease (NAFLD) or non-alcoholic steatohepatitis (NASH).
    Type: Application
    Filed: December 5, 2012
    Publication date: June 20, 2013
    Applicant: MediciNova, Inc.
    Inventor: MediciNova, Inc.